Skip to main content
logo
Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
India flag India · Delayed Price · Currency is INR
1,610.60
-28.30 (-1.73%)
At close: Jan 28, 2026

NSE:SUNPHARMA Revenue

Sun Pharmaceutical Industries had revenue of 144.78B INR in the quarter ending September 30, 2025, with 8.93% growth. This brings the company's revenue in the last twelve months to 549.64B, up 9.26% year-over-year. In the fiscal year ending March 31, 2025, Sun Pharmaceutical Industries had annual revenue of 525.78B with 8.42% growth.

Revenue (ttm)
549.64B
Revenue Growth
+9.26%
P/S Ratio
7.15
Revenue / Employee
12.78M
Employees
43,000
Market Cap
3.93T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025525.78B40.82B8.42%
Mar 31, 2024484.97B46.11B10.51%
Mar 31, 2023438.86B52.31B13.53%
Mar 31, 2022386.54B51.56B15.39%
Mar 31, 2021334.98B6.61B2.01%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Aurobindo Pharma325.14B
Cipla279.67B
Zydus Lifesciences244.94B
Glenmark Pharmaceuticals159.97B
Alkem Laboratories138.90B
Mankind Pharma135.46B
Divi's Laboratories100.29B
Ipca Laboratories93.59B
Revenue Rankings

Sun Pharmaceutical Industries News

More News